Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NeoTCR-P1 T-cells |
Trade Name | |
Synonyms | NeoTCR-P1 |
Drug Descriptions |
NeoTCR-P1 T-cells are autologous T-lymphocytes that are engineered to express patient-specific neoepitope T-cell receptors, which may induce an anti-tumor immune response (Cancer Res 2019;79(13 Suppl):Abstract nr 1433). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C161651 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NeoTCR-P1 T-cells | NeoTCR-P1 T-cells | 0 | 1 |
NeoTCR-P1 T-cells + Nivolumab | NeoTCR-P1 T-cells Nivolumab | 0 | 1 |